4D Molecular Therapeutics Inc (FDMT)

Cost of Revenue

$2.09M

Quarterly · Period ending: · USD

FDMT logo

FDMT Cost of Revenue

Latest reported$2.09M
FDMT Quarterly Cost of Revenue ($4.10M → $2.09M)
High-resolution chart · PNG

FDMT cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,089,000
2,055,000
1,980,000
47,238,000
47,951,000
40,699,000
1,784,000
38,484,000
31,860,000
27,870,000
26,028,000
25,066,000
23,584,000
22,412,000
21,500,000
18,940,000
20,422,000
19,381,000
17,528,000
15,840,000
15,223,000
12,769,000
12,605,000
11,555,000
15,720,000
13,158,000
12,359,000
9,374,000
8,492,500
8,492,500
5,077,000
5,077,000
4,104,000
4,104,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.